Amgen pledges $1.9bn to alliance with AI specialist Generate
Fresh from a sizeable funding round that raised $370 million, artificial intelligence-based drug discovery firm Generate Biomedicines has just signed
Fresh from a sizeable funding round that raised $370 million, artificial intelligence-based drug discovery firm Generate Biomedicines has just signed
The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a
COVID-19 research efforts are often described as a race between companies, a description that reflects the urgency to develop a vaccine for the novel
COVID-19 research efforts are often described as a race between companies, a description that reflects the urgency to develop a vaccine for the novel
COVID-19 research efforts are often described as a race between companies, a description that reflects the urgency to develop a vaccine for the novel
COVID-19 research efforts are often characterized as a race between companies, a description that reflects the urgency to develop a vaccine for the
When biotech startups emerge from stealth, executives typically talk about new molecules in the pipeline and novel approaches they take to treating a